Formulation Development Solutions

1. 4Cell® XtraCHO Media System 4/7/2021

   The 4Cell® XtraCHO Media System is for protein production using CHO systems. Use of production media and feeding supplements helps satisfying cell culture requirement using different approaches conditions. Recommended protocols facilitate easy and efficient identification of a feeding strategy.

2. in vitro Kill Rate Studies For Antimicrobial Screening 6/13/2025

   Utilize advanced in vitro time kill-rate studies to accurately assess antimicrobial activity, understand drug-microbe interactions, and evaluate the effectiveness of combination therapies.

3. Cell Therapy Product Characterization Services

   Our cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.

4. Biocatalysis For Cost-Efficient, Environmentally Friendly Manufacturing

   Biocatalysis enables cost efficient and environmentally friendly manufacturing through enzymatic synthesis and provides pure -regio, chemo- and enantioselective compounds when compared to traditional chemical synthesis.

5. Discovery Hybrid Rheometers: Temperature Systems And Accessories 4/6/2023

   Explore a wide variety of DHR temperature systems and accessories, designed for superior performance and ease-of-use.

6. Solutions For Aggregate And Fragment Analyses 6/30/2022

   Learn more about important considerations in peptides and SEC column separation and a SEC column technology solution.

7. PBPK Predictive Modeling Services

   Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.

8. GENE TO GMP*: First-In-Human In 8 Months With Optimized Cost 3/27/2025

   We drive innovation and excellence in biologics, offering integrated solutions that help clients efficiently advance their research and successfully bring their products to market.

9. High-Content Screening System 3/31/2025

   Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.

10. Controlled Substances

    Cambrex holds US Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing, and importation of Schedule I to IV controlled substances.